SOFHOUR Finance SOFHOUR Finance
IPO desk
Sign in
Report a bugTell us what went wrong. We read every report.

What kind of problem?

We also send the page link and your browser name, to help us fix it.

Healthcare · NIFTY 500

Syngene International Limited

NSESYNGENE BSE539268 ISININE398R01022 SeriesEQ Listed on NSE · BSE

₹449.00 +6.15 (+1.39%) Updated 12 Nov, 8:49 pm IST

Price, daily close-35.77% in a year

Today

Open
₹447.00
Prev close
₹442.85
Day high
₹449.50
Day low
₹441.00
Volume
5.46 L
Value traded
₹24.37 Cr
Upper circuit
₹531.40
Lower circuit
₹354.30
52W high
₹678.95
52W low
₹344.45
1 month
+20.01%
6 months
-13.94%
52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹18,126 Cr
P/E (TTM)97.19
P/B3.73
Book value / share₹120.36
EPS (TTM)₹4.62
ROE0.8%
Dividend yield0.28%
Dividend (12m)₹1.25 / share
Net margin (TTM)1.1%
Operating margin16.9%
Debt / equity0.01
Current ratio1.65
EV / EBITDA27.64
Sales growth (YoY qtr)-8.55%
Profit growth (YoY qtr)—
Sales CAGR 3Y+5.40%
Profit CAGR 3Y—
Shares40.37 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

854112
Dec 23
917189
Mar 24
79075.7
Jun 24
891106
Sep 24
9440.0
Dec 24
1,0180.0
Mar 25
8750.0
Jun 25
9110.0
Sep 25
91715.0
Dec 25
1,0370.0
Mar 26
736-9.0
Jun 26
83332.2
Sep 26

Revenue · QoQ (vs last quarter)

—+7.4%-14%+13%+5.9%+7.9%-14%+4.1%+0.7%+13%-29%+13%

Revenue · YoY (vs a year ago)

————+11%+11%+11%+2.2%-2.8%+1.8%-16%-8.6%

Net profit · QoQ (vs last quarter)

—+69%-60%+40%-100%————-100%—+458%

Net profit · YoY (vs a year ago)

————-100%-100%-100%-100%————
RevenueNet profitLine = trend
2.77
Dec 23
4.69
Mar 24
1.88
Jun 24
2.64
Sep 24
3.26
Dec 24
4.56
Mar 25
2.15
Jun 25
1.67
Sep 25
0.37
Dec 25
3.67
Mar 26
-0.22
Jun 26
0.80
Sep 26

EPS (₹) · YoY (vs a year ago)

————+18%-2.8%+14%-37%-89%-20%-110%-52%
EPS (₹)Line = trend

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

1,826537332
FY19
2,0126890.0
FY20
2,184707405
FY21
2,6047650.0
FY22
3,1939340.0
FY23
3,4891,003510
FY24
3,6421,0740.0
FY25
3,7398420.0
FY26

Revenue · YoY (vs a year ago)

—+10%+8.6%+19%+23%+9.3%+4.4%+2.6%

Net profit · YoY (vs a year ago)

—-100%—-100%——-100%—
RevenueOperating profitNet profitLine = trend

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

3,61857589.5
Mar 23
4,25814285.7
Mar 24
4,727120367
Mar 25
4,8399.4229
Mar 26
4,85967.2120
Sep 26

Shareholders' equity · YoY (vs a year ago)

—+18%+11%+2.4%—
Shareholders' equityBorrowingsCashLine = trend

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

581-612-31.3
FY22
824-656-343
FY23
1,042-496-551
FY24
1,168-745-142
FY25
915-860-215
FY26

Operations · YoY (vs a year ago)

—+42%+27%+12%-22%
OperationsInvestingFinancingLine = trend

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

54.8%Dec 23
54.8%Mar 24
54.7%Jun 24
54.7%Sep 24
52.7%Dec 24
52.7%Mar 25
52.7%Jun 25
52.7%Sep 25
52.7%Dec 25
52.7%Mar 26
52.6%Jun 26
52.6%Sep 26
Promoter & groupPublic

Latest (30 Sep 2026)

52.6%promoter
Promoter & group
52.59%
Public (FIIs, mutual funds, retail…)
47.00%
Employee trusts
0.41%
Promoter change, last quarter
0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

  • Dividend - Rs 1.25 Per Share
  • Dividend - Rs 1.25 Per Share
  • Dividend - Rs 1.25 Per Share
  • Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
  • Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share
  • Annual General Meeting
  • Dividend - Rs 0.50 Per Share
  • Bonus 1:1

Board meetings

  • SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudite…
  • the financial results for the period ended September 30, 2026
  • SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Board Meeting to be held on 29-Jul-2026 to inter-alia consider and approve the Unaudite…
  • the financial results for the period ended Jun 30, 2026
  • the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.

Filings with NSE

  • Analysts/Institutional Investor Meet/Con. Call Updates
  • Copy of Newspaper Publication
  • Analysts/Institutional Investor Meet/Con. Call Updates
  • Investor Presentation
  • Resignation of Director/KMP/SMP
  • Press Release
  • Change in Management

About

About Syngene International Limited

Syngene International Limited is listed on the NSE under the symbol SYNGENE and belongs to the Healthcare sector.

Company details

Company name
Syngene International Limited
NSE symbol
SYNGENE
BSE scrip code
539268
ISIN
INE398R01022
Listed on
NSE, BSE
Series
EQ (normal equity)
Listed on NSE since
11 Aug 2015
Face value
₹10 per share
Market lot
1 share
Shares issued
40.37 crore
Index
NIFTY 500
Sector (NSE)
Healthcare
Industry
Miscellaneous Commercial Services
Managing director / CEO
Siddarth Mittal
Chair
Kiran Mazumdar Shaw
Headquarters
Bengaluru, Karnataka, India
Registered address
The Hub', Tower 8A, 360 Degree Business Park, Doddathoguru, Electronic City, Phase 1, Bengaluru, Karnataka 560100
Founded
1993
Employees
8,376
Financial year
April to March
Results basis
Consolidated

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.